Keyword: Bristol-Myers Squibb (BMS)
News
08.07.2019
- Catalent Biologics, through its Paragon Gene Therapy business, has agreed to assume the leases to two Novavax facilities in Maryland, USA. The move, said Novavax, will reduce its...
News
24.06.2019
- Continuing a buying spree that has added adding biologics and gene therapy capabilities to its manufacturing repertoire, California-based US drug developer Catalent is buying a...
News
17.04.2019
- Shareholders of Bristol Myers Squibb (BMS) have approved the company’s $74 billion acquisition of Celgene. At the special meeting on Apr. 12, altogether 75% of the shareholders...
Strategy & Management
08.04.2019
- The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious...
News
02.04.2019
- Activist investor Starboard Value has backed away from plans to torpedo the proposed $74 billion merger of Bristol-Myers Squibb with Celgene after independent proxy advisory firms...
News
01.03.2019
- Activist investor Starboard Value, which very recently bought a 1 million share in Bristol-Myers Squibb (BMS) and nominated five directors to the board, has now made public its...
News
22.02.2019
- Activist shareholder Starboard Value has acquired an interest of 1 million share of Bristol-Myers Squibb (BMS) and has held meetings with management, the US drugmaker said. BMS...
News
18.02.2019
- Within a week, US biotech Celgene, which is in the process of being acquired by Bristol-Myers-Squibb (BMS), dodged a challenge to its patent for the blockbuster multiple myeloma...
